93 7530 (Metformin Hydrochloride and Rosiglitazone Maleate 500 mg / 1 mg)
Pill with imprint 93 7530 is Yellow, Elliptical / Oval and has been identified as Metformin Hydrochloride and Rosiglitazone Maleate 500 mg / 1 mg. It is supplied by Teva Pharmaceuticals USA, Inc..
Metformin/rosiglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metformin/rosiglitazone 500 mg / 1 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 7530
Metformin Hydrochloride and Rosiglitazone Maleate
- Imprint
- 93 7530
- Strength
- 500 mg / 1 mg
- Color
- Yellow
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA, Inc.
- National Drug Code (NDC)
More about metformin / rosiglitazone
- Side Effects
- During Pregnancy
- Dosage Information
- Imprints, Shape & Color Data
- Drug Interactions
- 3 Reviews
- Drug class: antidiabetic combinations
- FDA Alerts (7)
Consumer resources
- Other brands
- Avandamet
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.